Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2023 05:37 ET | Source: Transparency Market Research

Warts Therapeutics Market to Exceed USD 2.5 billion by 2030, Garnering 3.0% CAGR Says, Transparency Market Research

Wilmington, Delaware, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The warts therapeutics market was estimated to have acquired US$ 1.92 billion in 2018. It...
September 28, 2021 14:49 ET | Source: The Insight Partners

Warts Therapeutics Market Size to Outstrip $2,314.60Mn by 2028 Growth Projections at 3.4% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com

New York, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Warts Therapeutics Market: Key InsightsAccording to our new research study on “Warts Therapeutics Market to 2028 – Global Analysis and Forecast – by...
July 26, 2021 20:00 ET | Source: DelveInsight Business Research LLP

Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape

Los Angeles, July 26, 2021 (GLOBE NEWSWIRE) -- Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape With...
July 22, 2021 08:40 ET | Source: CMI

Global Genital Warts Treatment Market to Surpass US$ 2,253.6 Million by 2028, Says Coherent Market Insights (CMI)

SEATTLE, July 22, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global genital warts treatment market is estimated to be valued at US$ 1,628.9 million in 2021 and is expected to...
July 24, 2019 08:30 ET | Source: Novan, Inc.

Novan’s Drug Substance Demonstrates Inhibition of HPV-18 Virus Production

Preclinical data published in Antiviral ResearchStudy conducted by Drs. N.S. Banerjee, L.T. Chow and T.R. Broker at The University of Alabama at BirminghamFindings reinforce anti-viral mechanism of...
November 01, 2018 08:05 ET | Source: Novan, Inc.

Novan Publication Supports Women’s Health Business Unit Initiative and Nitric Oxide’s Potential Against HPV-Associated Diseases

Data from SB206 Phase 2 clinical trial in external genital warts have been published in the Journal of Drugs in DermatologySB206 was efficacious and well tolerated in the trialAdvancement of the late...
May 20, 2015 08:30 ET | Source: AIM ImmunoTech Inc.

Hemispherx to Present at the Marcum Microcap Conference in New York

PHILADELPHIA, May 20, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) will present at the Marcum Microcap Conference being held at the Grand Hyatt Hotel in New York City on Wednesday, May...
March 04, 2013 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection(R) in Argentina

PHILADELPHIA, March 4, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that ANMAT (Administracion Nacional de Medicamentos, Alimentos y...